N,N'-bis[(4-trifluoromethyl)phenyl]malonodiamide | 7574-50-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N,N'-bis[(4-trifluoromethyl)phenyl]malonodiamide
• 英文别名: N,N'-bis-(4-trifuoromethyl-phenyl)-malonamide；N,N'-bis[4-(trifluoromethyl)phenyl]propanediamide
• CAS: 7574-50-7
• 化学式: C₁₇H₁₂F₆N₂O₂
• 分子量: 390.285
• InChiKey: OHZRTCGRKGZNAL-UHFFFAOYSA-N

物化性质

• 沸点：
  536.0±50.0 °C(Predicted)
• 密度：
  1.461±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  N,N'-bis[(4-trifluoromethyl)phenyl]malonodiamide 在 磷酸酐 、 甲烷磺酸 、 三氯氧磷 作用下， 以 1,4-二氧六环 为溶剂， 反应 0.58h， 生成 2,4-二氯-6-三氟甲基喹啉
  参考文献：
  名称：

  微波催化钯催化交叉偶联化学合成功能化4-芳基喹啉-2（1 H）-ones

  摘要：

  已经使用容易获得的4-羟基喹啉-2（1H）-作为中间体以短而简明的方式合成了具有生物活性的4-芳基-3-烯基取代的喹啉-2（1 H）- 。合成中的关键步骤包括使用钯催化的Suzuki和Heck反应衍生化喹啉2（1 H）-1核，并安装4-芳基和3-烯基取代基。使用受控的微波辅助有机合成进行所需目标喹啉-2（1 H）-1合成所需的所有合成转化（六个步骤）。

  DOI：

  10.1021/jo0502549
• 作为产物：
  描述：

  对三氟甲基苯胺 、 丙二酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以95%的产率得到N,N'-bis[(4-trifluoromethyl)phenyl]malonodiamide
  参考文献：
  名称：

  A New Rational Hypothesis for the Pharmacophore of the Active Metabolite of Leflunomide, a Potent Immunosuppressive Drug

  摘要：

  Leflunomide is one of the most promising disease-modifying antirheumatic drug now in clinical trials for the treatment of rheumatoid arthritis. Metabolic studies have indicated that leflunomide is rapidly processed in vivo to an active metabolite, A771726 (2). To identify the chemical characteristics necessary for the immunosuppressive activity of 2, configurational and conformational studies were carried out on the latter and its inactive analogues (ethyl 3-hydroxy-2-((4-(trifluoromethyl)phenyl)carbamoyl)but-2-enoate 3a, and 3-hydroxy-2-nitro-N(4-(trifluoromethyl)phenyl)but-2 -enamide, 3b). These studies suggested that the pharmacophore responsible for the immunosuppressive activity of 2 is a beta-keto amide with the enolic hydroxy group cis to the amidic moiety. To verify this hypothesis, a new class of immunosuppressive agents was designed and synthesized. Their testing in vitro and in vivo identified compounds which were more potent than both leflunomide and 2 and above all confirmed our hypothesis as to the key structural and chemical determinants for the immunosuppressive properties of 2 and our compounds.

  DOI：

  10.1021/jm970039n

文献信息

• Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis
  申请人：Cai Xiong Sui

  公开号：US20070043076A1

  公开（公告）日：2007-02-22

  The present invention is directed to substituted 2-arylmethylene-N-aryl-N′-aryl-malonamides and analogs thereof. The present invention also relates to the discovery that the compounds are activators of caspases and inducers of apoptosis. Therefore, the activators os caspases and inducers of apoptosis of this invention can be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.

  本发明涉及取代的2-芳基亚甲基-N-芳基-N'-芳基-马隆酰胺及其类似物。本发明还涉及发现这些化合物是caspase的激活剂和凋亡诱导剂。因此，本发明的caspase激活剂和凋亡诱导剂可用于诱导各种临床情况下不受控制的异常细胞的生长和扩散。
• [EN] SUBSTITUTED 2-ARYLMETHYLENE-N-ARYL-N'-ARYL-MALONAMIDES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS<br/>[FR] MALONAMIDES 2-ARYLMETHYLENE-N-ARYL-N'-ARYL SUBSTITUES ET LEURS ANALOGUES UTILES COMME ACTIVATEURS DES CASPASES ET INDUCTEURS DE L'APOPTOSE
  申请人：CYTOVIA INC

  公开号：WO2005037196A2

  公开（公告）日：2005-04-28

  The present invention is directed to substituted 2-arylmethylene-N-aryl-N'-aryl-malonamides and analogs thereof. The present invention also relates to the discovery that the compounds are activators of caspases and inducers of apoptosis. Therefore, the activators os caspases and inducers of apoptosis of this invention can be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of anormal cells occurs.
• A New Rational Hypothesis for the Pharmacophore of the Active Metabolite of Leflunomide, a Potent Immunosuppressive Drug
  作者：Giorgio Bertolini、Mario Aquino、Mauro Biffi、Gaetano d'Atri、Francesco Di Pierro、Francesco Ferrario、Paolo Mascagni、Flavio Somenzi、Andrea Zaliani、Flavio Leoni

  DOI：10.1021/jm970039n

  日期：1997.6.1

  Leflunomide is one of the most promising disease-modifying antirheumatic drug now in clinical trials for the treatment of rheumatoid arthritis. Metabolic studies have indicated that leflunomide is rapidly processed in vivo to an active metabolite, A771726 (2). To identify the chemical characteristics necessary for the immunosuppressive activity of 2, configurational and conformational studies were carried out on the latter and its inactive analogues (ethyl 3-hydroxy-2-((4-(trifluoromethyl)phenyl)carbamoyl)but-2-enoate 3a, and 3-hydroxy-2-nitro-N(4-(trifluoromethyl)phenyl)but-2 -enamide, 3b). These studies suggested that the pharmacophore responsible for the immunosuppressive activity of 2 is a beta-keto amide with the enolic hydroxy group cis to the amidic moiety. To verify this hypothesis, a new class of immunosuppressive agents was designed and synthesized. Their testing in vitro and in vivo identified compounds which were more potent than both leflunomide and 2 and above all confirmed our hypothesis as to the key structural and chemical determinants for the immunosuppressive properties of 2 and our compounds.
• Microwave-Assisted Multistep Synthesis of Functionalized 4-Arylquinolin-2(1<i>H</i>)-ones Using Palladium-Catalyzed Cross-Coupling Chemistry
  作者：Toma N. Glasnov、Wolfgang Stadlbauer、C. Oliver Kappe

  DOI：10.1021/jo0502549

  日期：2005.5.1

  been synthesized in a short and concise manner employing readily available 4-hydroxyquinolin-2(1H)-ones as intermediates. Key steps in the synthesis include the derivatization of the quinolin-2(1H)-one cores using palladium-catalyzed Suzuki and Heck reactions, installing the 4-aryl and 3-alkenyl substituents. All synthetic transformations (six steps) required for the synthesis of the desired target

  已经使用容易获得的4-羟基喹啉-2（1H）-作为中间体以短而简明的方式合成了具有生物活性的4-芳基-3-烯基取代的喹啉-2（1 H）- 。合成中的关键步骤包括使用钯催化的Suzuki和Heck反应衍生化喹啉2（1 H）-1核，并安装4-芳基和3-烯基取代基。使用受控的微波辅助有机合成进行所需目标喹啉-2（1 H）-1合成所需的所有合成转化（六个步骤）。